The Pros And Cons Of Publishing Non-Interventional Study Data – As Seen By Sanofi & GSK

 
• By Vibha Sharma
  
clinicaltrials.gov
Ethic Committees Expect Non-Interventional Studies To Be Listed On A Public Registry • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D